Source: StreetInsider

Press Release: Novus Scientific : Erasmus University MC investigating a new surgical matrix to reduce post-operative complications

The synthetic and fully resorbable TIGR®Matrix surgical mesh (Novus Scientific AB, Uppsala − Sweden) might be an interesting candidate for the prevention of complications frequently observed with permanent mesh placement, according to Professor Johan Lange of the Erasmus University in Rotterdam − the Netherlands.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Thomas Engstrom's photo - CEO of Novus Scientific

CEO

Thomas Engstrom

CEO Approval Rating

65/100

Read more